The ROE as of December 2024 (TTM) for Axcella Health Inc. (AXLA) is -620.40%

According to Axcella Health Inc.’s latest financial reports and current stock price. The company's current ROE is -620.40%. This represents a change of 252.67% compared to the average of -175.92% of the last 4 quarters.

Axcella Health Inc. (AXLA) Historical ROE (quarterly & annually)

How has AXLA ROE performed in the past?

The mean historical ROE of Axcella Health Inc. over the last ten years is -413.34%. The current -620.40% ROE has changed 50.10% with respect to the historical average. Over the past ten years (40 quarters), AXLA's ROE was at its highest in in the September 2022 quarter at 246.15%. The ROE was at its lowest in in the December 2022 quarter at -582.54%.

Axcella Health Inc. (AXLA) ROE by Quarter and Year

Discovering the peaks and valleys of Axcella Health Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Axcella Health Inc. (AXLA) Average ROE

How has AXLA ROE performed in the past?

The current ROE of Axcella Health Inc. (AXLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Axcella Health Inc. (AXLA) ROE vs. Peers

How is AXLA’s ROE compared to its peers?

Axcella Health Inc.’s ROE is greater than Cyclerion Therapeutics, Inc. (-55.31%), greater than Magenta Therapeutics, Inc. (-14.27%), greater than Kezar Life Sciences, Inc. (-59.73%), less than ContraFect Corporation (376.50%), less than Panbela Therapeutics, Inc. (304.71%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Aridis Pharmaceuticals, Inc. (-90.29%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than Assembly Biosciences, Inc. (-121.46%), greater than Instil Bio, Inc. (-37.44%), greater than Nuvation Bio Inc. (-108.68%), less than Akari Therapeutics, Plc (550.78%), greater than Salarius Pharmaceuticals, Inc. (-140.30%), greater than Histogen Inc. (-80.69%), greater than RenovoRx, Inc. (-242.57%), greater than Adial Pharmaceuticals, Inc. (-256.25%), less than Better Therapeutics, Inc. (129.80%), greater than Pasithea Therapeutics Corp. (-81.66%),

Build a custom stock screener for Axcella Health Inc. (AXLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axcella Health Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axcella Health Inc. (AXLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axcella Health Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.